Abstract

The American Diabetes Association (ADA) responds to letters concerning published articles in Diabetes Care . It does not respond to letters concerning presentations at the ADA Annual Scientific Sessions or reports of such presentations. The ADA held an entire conference on the treatment of gestational diabetes in November 2005, in which the use of metformin was discussed. On 12 June 2005, the ADA’s newsletter from the 65th Annual Scientific Sessions, the Bayside Tribune (1), ran a piece entitled “Metformin Shown to be Safe and Effective in Pregnancy”. The article erroneously stated that speakers at a symposium answered “with a resounding ‘Yes’” to the question of whether metformin is safe and effective for diabetes in pregnancy. We are concerned with that message. A symposium entitled “Metformin in Pregnancy–Is it Safe? Does it Work?” discussed metformin in pregnancy. Dr. Clifford Bailey reviewed cellular mechanisms of metformin …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call